Sintx Technologies, Inc. Stock: price and insider trades · United States

Sintx Technologies, Inc., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to SEC (Form 4). The last twelve months, up to 22 October 2026, brought 19 filings signed by 5 insiders.

Only purchases show up on the open market, 17 purchases in all worth €240k, filed by 4 insiders. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Biggest ticket of the year: €19k, bought by Lyons Christopher Michael and made public on 10 March 2026. On the buying side, the filings list 4 senior executives among the declarants.

Within a 30-day window, 3 purchases overlapped with buying by a second insider. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The clock since the last published purchase (10 March 2026) now reads 227 days. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade.

For context, the typical company on the same exchange (median of 5,462 companies) published 28 filings over the same period, against 19 filings here. Looking back to 2020, when coverage begins, insiders filed 46 purchases and 1 sale. For the fiscal year to 31 December 2025, the annual 10-K puts revenue at 1.0 m USD and net income at -10.4 m USD.

For comparison within the same sector, see the insider buying recorded at Xenon Pharmaceuticals Inc. and Vivos Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.